In 2008 and 2009 increased numbers of pertussis notifications were reported in NSW. During the epidemic period, the pertussis notification rate was 2.7 times higher than the previous 5-year average. Rates of pertussis notifications and hospitalisations were highest among infants aged less than 1 year across all years studied. Compared to previous years, the notification rate for children aged 1-4 years increased dramatically and was particularly striking for children aged 3 years with notifications exceeding those for infants in 2009. Changes in testing practices during the epidemic period, including a significant increase in the use of polymerase chain reaction, may account for some of the relative increase in size of the
Pertussis, or whooping cough, is a bacterial infection of the respiratory tract caused by Bordetella pertussis. Pertussis usually begins with symptoms similar to a cold, with a runny nose, tiredness and sometimes a mild fever. A cough then develops, usually in bouts (paroxysms), followed by a deep gasp (or whoop). Pertussis affects people of all ages, however, infants are at greatest risk of severe disease, complications, hospitalisation and death. 1 Parents, siblings and close contacts are the most important sources of pertussis infection to infants. 2 Control of pertussis is problematic because of its high degree of communicability and because immunity, whether from immunisation or infection, wanes after approximately 6-10 years, resulting in renewed susceptibility to infection. In NSW, periodic epidemics of pertussis occur at intervals of 3-4 years, on a background of endemic circulation. 3 The current NSW immunisation schedule for pertussis includes a primary course of diphtheria-tetanus-acellular pertussis (DTPa) vaccine at 2, 4 and 6 months of age with a booster dose at 4 years of age. Several modifications to this immunisation schedule have occurred since the vaccine's introduction. In 1997, DTPa vaccines replaced diphtheriatetanus-whole cell pertussis (DTPw) vaccines for booster doses and from 1999 for all doses. Prior to September 2003, an 18-month booster was included in the schedule, however this was removed based on evidence that three doses of acellular pertussis vaccine in the first year of life provide adequate protection until the age of 6 years. 4 From the beginning of 2004, an adolescent/adult formulated booster (dTpa) replaced the use of the adult diphtheriatetanus vaccine (dT) at 15-17 years. The latter change was prompted by a shift in notifications to this age group following the introduction of the booster dose at 4-5 years in 1994. 5 From 2003, dTpa was also recommended for use in adults who were in contact with young infants (e.g. new parents, childcare and healthcare staff), but was not funded under the National Immunisation Program.
The coverage of pertussis vaccination in the community at 12 and 24 months of age has substantially increased in NSW during the last decade. The Australian Bureau of Statistics (ABS) found coverage with three doses of DTPw at 12-23 months of age was recorded at 87% and at 60% for four doses of DTPw at 24 months during 1995. 6 The national immunisation coverage annual report, while using different survey methods, found that coverage had risen to 92% for three doses of DTPa at 12 months and 95% for the reduced schedule of three doses of DTPa at 24 months in March 2008. 7 Due to the abovementioned changes in pertussis vaccination within the National Immunisation Program, and changes in vaccine coverage, several cohorts of people with different vaccination histories now exist within the population. In NSW, epidemics occurred in 1993-1994, 1997-1998 and 2000-2002, with successive upward shifts in the age distribution of cases. 8 The most recent epidemic in 2005 was dominated by cases in adults whose disease was largely diagnosed by serology. 9 In this paper we review the epidemiology of pertussis cases notified in NSW since 1998.
Method

NSW notification data
Pertussis notification data from the NSW Notifiable Diseases Database were reviewed for cases with a date of onset between 1 January 1998 and 31 December 2009. Vaccination status and morbidity and mortality outcomes for notified cases were obtained through follow-up by NSW public health units. All rates were calculated using ABS population estimates for the relevant year. Rates are presented as annual rates per 100 000 total population or in age groups, as appropriate.
Systems for the diagnosis and counting of cases of pertussis have changed over time. From 1 January 2007, the manufacturer of a widely used commercial Bordetella IgA assay changed the recommended cut-off titres for a commonly used serological test used across NSW. From 1 January 2009, NSW ceased collecting data about suspected cases of pertussis in accordance with national surveillance protocols. 10 
NSW hospitalisations
Pertussis hospitalisations were obtained from the NSW Inpatients Statistics Collection with an admission date between 1 January 1998 and 31 December 2009. All rates were calculated using ABS population estimates for the relevant year. Rates are presented as annual rates per 100 000 total population or population in age groups, as appropriate. Eligible hospitalisations were those with an International Classification of Diseases, tenth revision (IDC-10-AM) code of A37 (whooping cough) or a subcode, listed in the principal diagnosis or in any other diagnosis. Medians are used to describe the length of stay per admission episode as these data are not distributed normally. July Jan-99 July Jan-00 July Jan-01 July Jan-02 July Jan-03 July Jan-04 July Jan-05 July Jan-06 July Jan-07 July Jan-08 July Jan-09 July
Results
Pertussis notification and hospitalisation trends
Number 
Age distribution
Age-specific notification rates are shown in Figures 2  and 3 . The pertussis notification rate was highest among infants aged less than 1 year in the majority of years studied (annual average rate of 165 per 100 000 population). In 2001, the highest age-specific notification rate was for young people aged 10-14 years (2650 per 100 000 population). Notifications in young people aged 10-14 years peaked again during the 2008 (277 per 100 000 population) and 2009 (339 per 100 000 population) epidemic period. Notification rates for adults aged greater than 20 years hospitalisation rate was highest among infants aged less than 1 year in all years studied, with an annual average of 151.6 per 100 000 population. Hospitalisation rates for children aged 1-19 years were relatively low in the early part of this decade and remained low until the current epidemic in 2008-2009. The 2008-2009 hospitalisation rates for infants aged less than 1 year and children aged 1-4 years were 4.3 and 4.5-fold higher respectively than the previous 5-year average for each age group. In contrast to children, the hospitalisation rate among adults aged 60 years and over has steadily increased, rising from 1.1 per 100 000 population in 1999 to a peak of 6.8 per 100 000 population in 2009. The 2008-2009 hospitalisation rate for adults aged 60 years and over was 1.8-fold higher than the previous 5-year average for this age group. Over the epidemic period, the average notification rate varied across geographical areas (from 86 per 100 000 population in rural New England to 285 per 100 000 population in Northern Rivers). As with other years, the highest age-specific rates were reported from cases aged less than 1 year across all areas. A similar pattern of variation was observed in the hospitalisation data, however those AHSs with the highest notification rates did not always have the highest hospitalisation rates (Table 1) . Table 2 ). For infants aged less than 1 year, the median length of stay decreased with increasing age. Intensive care unit admissions were more common in very young infants and elderly people ( Table 2) . One in 13 infants less than 2 months of age hospitalised with pertussis required an intensive care unit admission during their stay. As with previous outbreak years, the highest age-specific rates were reported from infants aged less than 1 year. Notification rates also increased in children aged 1-4 and Among cases aged 0-5 years, the greatest increase was noted for children aged 3 years. Further analysis of notification data for this age group will need to be undertaken to assess the possible effects of changes in immunisation policy in NSW.
Vaccination status
Method of diagnosis
To help protect infants and children during the epidemic, NSW Health advised parents and general practitioners that the first dose of DTPa vaccine (usually given at 2 months) could be given as early as 6 weeks of age and that the scheduled fourth dose (usually given at 4 years) could be administered from the age of 3 years and 6 months, to provide earlier protection against pertussis. 11 In addition, NSW Health provided free (dTpa) vaccine for all new parents, grandparents and other adults who regularly care for infants aged less than 1 year.
Conclusion
This review of pertussis notifications and hospitalisations during the 2008-2009 epidemic identified epidemiological differences compared to previous outbreak years. The age distribution of cases, specifically those aged 0-4 years, will require further investigation to determine the impact of changes to immunisation policy on pertussis notifications. The range of public health control measures that were implemented in NSW in response to the epidemic will require further evaluation.
